CY1110975T1 - Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του - Google Patents
Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης τουInfo
- Publication number
- CY1110975T1 CY1110975T1 CY20101101136T CY101101136T CY1110975T1 CY 1110975 T1 CY1110975 T1 CY 1110975T1 CY 20101101136 T CY20101101136 T CY 20101101136T CY 101101136 T CY101101136 T CY 101101136T CY 1110975 T1 CY1110975 T1 CY 1110975T1
- Authority
- CY
- Cyprus
- Prior art keywords
- crystall
- united
- industry
- production
- sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Κρυσταλλική μορφή του Ν-(3-κυανιο-4-μεθυλ-1Η-ινδολ-7-υλ)-3-κυανιοβενζολιοσουλφοναμιδίου έχουσα κορυφή περιθλάσεως σε γωνία περιθλάσεως (2Θ ± 0.2°) ίση με 19,1° σε μία περίθλαση ακτίνων Χ κόνεως.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003318953 | 2003-09-10 | ||
| EP04772605A EP1666463B1 (en) | 2003-09-10 | 2004-09-01 | Crystal of sulfonamide-containing indole compound and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110975T1 true CY1110975T1 (el) | 2015-06-11 |
Family
ID=34308544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101101136T CY1110975T1 (el) | 2003-09-10 | 2010-12-10 | Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7754894B2 (el) |
| EP (1) | EP1666463B1 (el) |
| JP (1) | JP4435090B2 (el) |
| KR (1) | KR20060120644A (el) |
| CN (2) | CN101165049A (el) |
| AT (1) | ATE486849T1 (el) |
| AU (1) | AU2004272400B2 (el) |
| BR (1) | BRPI0414314A (el) |
| CA (1) | CA2536995C (el) |
| CY (1) | CY1110975T1 (el) |
| DE (1) | DE602004029907D1 (el) |
| DK (1) | DK1666463T3 (el) |
| ES (1) | ES2354286T3 (el) |
| HK (1) | HK1092796A1 (el) |
| HR (1) | HRP20100631T1 (el) |
| IL (2) | IL174059A0 (el) |
| MX (1) | MXPA06002732A (el) |
| NO (1) | NO335256B1 (el) |
| NZ (1) | NZ546111A (el) |
| PL (1) | PL1666463T3 (el) |
| PT (1) | PT1666463E (el) |
| RU (1) | RU2336269C2 (el) |
| SI (1) | SI1666463T1 (el) |
| TW (1) | TW200514770A (el) |
| WO (1) | WO2005026118A1 (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004029907D1 (de) * | 2003-09-10 | 2010-12-16 | Eisai R&D Man Co Ltd | Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3868534B2 (ja) * | 1996-05-24 | 2007-01-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド誘導体の製造法および中間体 |
| JP2000247949A (ja) * | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
| JP4039856B2 (ja) * | 2000-02-03 | 2008-01-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | インテグリン発現阻害剤 |
| TWI283575B (en) * | 2000-10-31 | 2007-07-11 | Eisai Co Ltd | Medicinal compositions for concomitant use as anticancer agent |
| DE602004029907D1 (de) * | 2003-09-10 | 2010-12-16 | Eisai R&D Man Co Ltd | Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung |
-
2004
- 2004-09-01 DE DE602004029907T patent/DE602004029907D1/de active Active
- 2004-09-01 RU RU2006111454/04A patent/RU2336269C2/ru not_active IP Right Cessation
- 2004-09-01 CN CNA2007101667949A patent/CN101165049A/zh active Pending
- 2004-09-01 EP EP04772605A patent/EP1666463B1/en active Active
- 2004-09-01 CN CNB2004800260696A patent/CN100406440C/zh not_active Expired - Fee Related
- 2004-09-01 NZ NZ546111A patent/NZ546111A/en not_active IP Right Cessation
- 2004-09-01 AU AU2004272400A patent/AU2004272400B2/en not_active Ceased
- 2004-09-01 CA CA2536995A patent/CA2536995C/en not_active Expired - Fee Related
- 2004-09-01 PL PL04772605T patent/PL1666463T3/pl unknown
- 2004-09-01 DK DK04772605.4T patent/DK1666463T3/da active
- 2004-09-01 US US10/571,279 patent/US7754894B2/en active Active
- 2004-09-01 KR KR1020067004877A patent/KR20060120644A/ko active Search and Examination
- 2004-09-01 WO PCT/JP2004/012649 patent/WO2005026118A1/ja active Application Filing
- 2004-09-01 JP JP2005513843A patent/JP4435090B2/ja not_active Expired - Fee Related
- 2004-09-01 ES ES04772605T patent/ES2354286T3/es active Active
- 2004-09-01 BR BRPI0414314-0A patent/BRPI0414314A/pt not_active IP Right Cessation
- 2004-09-01 SI SI200431578T patent/SI1666463T1/sl unknown
- 2004-09-01 MX MXPA06002732A patent/MXPA06002732A/es active IP Right Grant
- 2004-09-01 AT AT04772605T patent/ATE486849T1/de active
- 2004-09-01 PT PT04772605T patent/PT1666463E/pt unknown
- 2004-09-06 TW TW093126889A patent/TW200514770A/zh not_active IP Right Cessation
-
2006
- 2006-03-02 IL IL174059A patent/IL174059A0/en not_active IP Right Cessation
- 2006-04-05 NO NO20061545A patent/NO335256B1/no not_active IP Right Cessation
- 2006-12-06 HK HK06113378.9A patent/HK1092796A1/xx not_active IP Right Cessation
-
2009
- 2009-01-18 IL IL196569A patent/IL196569A0/en unknown
- 2009-06-09 US US12/480,959 patent/US20090247768A1/en not_active Abandoned
-
2010
- 2010-11-22 HR HR20100631T patent/HRP20100631T1/hr unknown
- 2010-12-10 CY CY20101101136T patent/CY1110975T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2020010I1 (no) | fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat | |
| CY2016013I1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν βαλσαρτανη και αναστολεις nep | |
| CY1106425T1 (el) | Ενωσις βενζυλαμινης και φαρμακευτικη χρησις αυτης | |
| CY1112916T1 (el) | 3-ζ-1-(4-(ν-((4-μεθυλ-πιπεραζιν-1-υλ)-μεθυλκαρβονυλ)-ν-μεθυλ-αμινο)-ανιλινο)-1-φαινυλ-μεθυλενο-6-μεθοξυκαρβονυλ-2-ινδολινονη-μονοαιθανοσουλφονικη και η χρηση αυτης ως φαρμακευτικη συνθεση | |
| CY1108725T1 (el) | Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer | |
| CY1112938T1 (el) | Παραγωγα n-φαινυλ-2-πυριμιδινης-αμινης | |
| DE60217363D1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen-abhängigen erkrankungen | |
| ATE502596T1 (de) | Schmales zahnimplantat und zugeordnete teile | |
| HK1145628A1 (en) | Pharmaceutical compositions having an analgesic effect and containing 1- benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides or related compounds | |
| FR2853631B1 (fr) | Materiau d'emballage et procede pour sa production | |
| PT1465864E (pt) | Inibidores de factor xa e outras serina proteases envolvidos na cascata da coagulacao | |
| WO2005038523A3 (en) | Imprint lithography templates having alignment marks | |
| CY1107913T1 (el) | Πολυμορφικες και αλλες κρυσταλλικες μορφες cis-ftc | |
| ATE458465T1 (de) | Kosmetische und/oder dermatologische zusammensetzung mit bornitrid | |
| DE602004019795D1 (de) | Kombination aus n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-ä1,3,4-oxadiazol-2-ylüphenyl)pyridin-3-sulfonamid und einem biphosphonat | |
| CY1107696T1 (el) | Συνδιασμος εταβονικης λοτεπρεδνολης και dfho για την αντιμετωπιση αναπνευστικων παθησεων, αλλεργικων παθησεων, ασθματος και copd | |
| BRPI0614533A2 (pt) | composição cosmética destinada à proteção e/ou à reparação dos materiais queratínicos, composto, processo de síntese de uma polilisina de cadeia graxa, e, utilização de uma composição cosmética | |
| NO20062599L (no) | Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav | |
| DE50210584D1 (de) | Sichter zum Sichten von körnigem Gut | |
| CY1110975T1 (el) | Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του | |
| FR2840799B1 (fr) | Vis d'osteosynthese | |
| DE60228183D1 (de) | Fotopolymerisierbare Zusammensetzung und Aufzeichnungsmaterial | |
| CY1106543T1 (el) | Μεθοδος συνθεσεως υπερινδοπριλης και τα φαρμακευτικως αποδεκτα αλατα αυτης | |
| ITBO20020034A1 (it) | Macchina per la realizzazione di confezioni cosiddette "strip" | |
| PL379628A1 (pl) | Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli |